Cholesterol. Research shows medium chain triglycerides (MCTs) may have a positive effect on cholesterol levels by lowering bad (LDL) cholesterol and elevating good (HDL) cholesterol by stimulating metabolism. MCTs may even diminish the cholesterol-elevating effects of other fats.
Blood Clotting. Unlike all other saturated and unsaturated fats, with the exception of omega-3 fatty acids (e.g. fish oil, flaxseed oil), MCTs are the only fats that do not increase platelet adhesiveness. Studies have proven Polynesian cultures that typically consume copious amounts of MCTs experience substantially less health problems associated with blood clotting in the arteries, including heart disease and stroke.
Chronic Infection. Recent research indicates that infection-causing microorganisms are involved in the formation of arterial plaque. MCT Lean MCT Oil contains an optimal ratio of caprylic and capric fatty acids that attack bacteria and viruses most notably linked to atherosclerosis.
Free-Radical Injury. One of the biggest threats to the heart and arteries comes from oxidized fat molecules embedded in rancid fats and highly processed vegetable oils. MCTs are so resistant to oxidation that in some instances they actually behave like an antioxidant, stopping other oils from becoming free radicals. By removing the main source of arterial injury and stopping further damage, MCTs promote arterial wall well-being.
Metabolic Syndrome. A 2008 study revealed that long-term ingestion of moderate amounts of MCTs might reverse metabolic syndrome, which is the name for a group of risk factors that occur together and increase the risk coronary artery disease, stroke, and type II diabetes.
Enig, M. G. (1999). Coconut: In support of good health in the twenty-first century. Paper presented at the Thirty-Sixth Annual Meeting of the APCC.
Enig, M. G. (2000). Know your fats: The complete primer for understanding the nutrition of fats, oils, and cholesterol. Silver Spring, Maryland: Bethesda Press.
Fife, B. (2004). The Coconut Oil Miracle. New York: Avery.
Greenberger, N. J. & Skillman, T. G. (1969). Medium-chain triglycerides: physiologic considerations and clinical applications. New England Journal of Medicine, 280.
Karup, P. A. & Rajmohan, T. (1994). Consumption of coconut oil and coconut kernel and the incidence of atherosclerosis. In Coconut and Coconut Oil in Human Nutrition, Proceedings. Symposium on Coconut and Coconut Oil in Human Nutrition, sponsored by the Coconut Development Board, Kochi, India, March 27, 1994.
Kaunitz, H. & Dayri, C. S. (1992). Coconut oil consumption and coronary heart disease. Philippine Journal of Internal Medicine, 30.
Prior, I. A., Davidson, F., Salmond, C. E. & Czochanska, Z. (1981). Cholesterol, coconuts, and diet on Polynesian atolls: A natural experiment: The Pukapuka and Tokelau Island studies. American Journal of Clinical Nutrition, 34(8).
Siri-Tarano, P. W., Sun, Q., Hu, F. B. & Krauss, R. M. (2010). Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. American Journal of Clinical Nutrition, 91(3).
St-Onge, M-P., Bosarge, A., Goree, L. L. T. & Darnell, B. (2008). Medium Chain Triglyceride Consumption as Part of a Weight Loss Diet Does Not Lead to an Adverse Metabolic Profile When Compared to Olive Oil. Journal of the American College of Nutrition, 27(5), 547-552.
Stanhope, J. M., Sampson V. M. & Prior, I. A. (1981). The Tokelau Island migrant study: Serum lipid concentrations in two environments. Journal of Chronic Diseases, 34.
Thampan, P. K. (1994). Facts and fallacies about coconut oil. Jakarta: Asian and Pacific Coconut Community.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.